In contrast to the ESR1 mutations, the PIK3CA mutations were not significantly more prevalent in ER + /HER2-disease compared to other breast cancer subtypes and 14% of the PIK3CA mutant samples had more than one PIK3CA mutation (Fig. 1d). This evidence concerns the gene ESR1 and breast carcinoma.